BRUKER CORPORATION

(BRKR)
  Report
Delayed Nasdaq  -  05/23 04:00:00 pm EDT
60.66 USD   +0.73%
05/16Bruker Board Declares Quarterly Dividend of $0.05 Per Common Share, Payable June 17 to Shareholders as of June 1
MT
05/16Bruker Announces Quarterly Dividend
BU
05/16Bruker Corporation Announces Quarterly Cash Dividend, Payable on June 17, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Bruker : Mestrelab and ZONTAL Support Efficient Life Science Research with Advanced Analytical Data Management and Molecular Analysis Software Platform

12/16/2021 | 12:29am EDT
Press Release
Mestrelab and ZONTAL Support Efficient Life Science Research with Advanced Analytical Data Management and Molecular Analysis Software Platform

SANTIAGO DE COMPOSTELA, Spain - December 15, 2021 - Mestrelab, a leading chemistry and life-science software company and ZONTAL, the provider of a leading analytical data hub, have developed an innovative analytical data management and analysis solution that eliminates many previous barriers. Developed for scientists in the life sciences, the ZONTAL and Mestrelab software integration enables efficient and effective utilization of analytical molecular data.

Data management systems often limit research efficiency through missing or complicated interfaces, redundant manual operations leading to underutilized data assets. ZONTAL and Mestrelab now provide the solution to these shortcomings with a powerful advanced analytical data management and analysis system that integrates the several key core capabilities of both companies: digital collaboration, data standardization, compliance data integrity, and automated analytical workflows.

Through the integration of ZONTAL's analytical data hub with Mestrelab's analytical data evaluation software, scientists using Mestrelab's Mnova can now directly query, process, and save data to and from the ZONTAL cloud. Also, data pipelines can be automated to allow scientists to run spectral analysis in less time than it takes to walk from their instrument to their desk.

The partnership of Mestrelab and ZONTAL will provide efficient workflows for improved digital data management

Santiago Dominguez, CEO of Mestrelab

Partnership is in the essence of Mestrelab, and it was natural for us to consider associating our solutions with an expert in digital lab transformation, archiving, and data standardization to give to our common end-users the best of the two worlds. We strive to provide our users with easy access to the data stored in their informatics platform of choice in a very intuitive way. At a time where AI and machine learning capabilities are key aspects of data usage, our integrated offering will allow our customers to additionally leverage the data in the AI/ML space.

Wolfgang Colsman, CEO of ZONTAL

Integrating with Mestrelab is a natural extension to the value that ZONTAL Space brings to our analytical chemistry customers. The vendor-neutral data format for NMR, LC/GC-MS, UV, IR, and other optical spectroscopy techniques eliminates the barriers to incorporating these key data assets into AI/ML workflows executed on the ZONTAL platform. Our customers are excited to unlock the value provided by this partnership.

Bruker is committed to expanding their cloud-based, scientific software for chemistry and pharma customers and to providing intuitive end-to-end solutions that make analysis and knowledge extraction in scientific research faster and easier. The ZONTAL and Mestrelab integration is the next step in advanced data management, combining innovative data storage and analysis solutions to help scientists realize the full potential and utilization of their available data assets.

About Mestrelab Research

Mestrelab Research SL (Mestrelab) , based in Santiago de Compostela, Spain, is an informatics company that develops and commercializes scientific software solutions for analytical chemistry and Laboratory Informatics in support of research, development, and manufacturing. Mestrelab's solutions are used globally in the biopharmaceutical, chemicals, agrochemicals, food and beverages, and other industries, academic institutions, and government organizations. The offer also includes integration with existing informatics systems and analytical laboratory automated workflows at an enterprise level. Mestrelab has initially developed highly innovative solutions for analytical chemistry and, more particularly, for NMR and LC/GC-MS, and has been, for almost a decade, the most widely used NMR processing solution. Mestrelab is majority-owned by Bruker Corporation (Nasdaq: BRKR).


About ZONTAL

ZONTAL, headquartered in Melbourne, Florida, offers a leading analytical data hub for the life science industry. We make digital transformation a reality as we deliver game-changing solutions to some of the most complex enterprises. We reduce IT overheads, enable AI/ML applications, optimize time-to-market, and increase compliance. Our customers celebrate our industry experience and ability to deliver highly intuitive solutions that empower scientists in their daily work. ZONTAL has offices in the US, Europe, and Asia. Together with our integration and service partners, ZONTAL supports our customers globally.

Media Contact (Bruker)

Thorsten Thiel
VP of Group Marketing
Bruker BioSpin
E: thorsten.thiel@bruker.com

Disclaimer

Bruker Corporation published this content on 15 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 December 2021 05:28:03 UTC.


© Publicnow 2021
All news about BRUKER CORPORATION
05/16Bruker Board Declares Quarterly Dividend of $0.05 Per Common Share, Payable June 17 to ..
MT
05/16Bruker Announces Quarterly Dividend
BU
05/16Bruker Corporation Announces Quarterly Cash Dividend, Payable on June 17, 2022
CI
05/10Bruker and TOFWERK Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions ..
BU
05/09Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets
BU
05/09Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets
CI
05/06BRUKER CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF..
AQ
05/05SVB Leerink Adjusts Bruker's Price Target to $87 from $85, Keeps Outperform Rating
MT
05/05Bruker Corporation acquired unknown minority stake in Tofwerk AG for CHF 18 million.
CI
05/04TRANSCRIPT : Bruker Corporation, Q1 2022 Earnings Call, May 04, 2022
CI
More news
Analyst Recommendations on BRUKER CORPORATION
More recommendations
Financials (USD)
Sales 2022 2 568 M - -
Net income 2022 300 M - -
Net Debt 2022 157 M - -
P/E ratio 2022 29,9x
Yield 2022 0,31%
Capitalization 8 988 M 8 988 M -
EV / Sales 2022 3,56x
EV / Sales 2023 3,30x
Nbr of Employees 7 765
Free-Float 57,8%
Chart BRUKER CORPORATION
Duration : Period :
Bruker Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BRUKER CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 60,22 $
Average target price 75,63 $
Spread / Average Target 25,6%
EPS Revisions
Managers and Directors
Frank H. Laukien Chairman, President & Chief Executive Officer
Gerald N. Herman Chief Financial Officer & Executive Vice President
William Alderman Linton Lead Independent Director
Richard A. Packer Independent Director
Hermann Fritz Requardt Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BRUKER CORPORATION-28.23%8 988
THERMO FISHER SCIENTIFIC-16.80%217 320
DANAHER CORPORATION-23.47%180 262
INTUITIVE SURGICAL, INC.-39.03%78 637
SIEMENS HEALTHINEERS AG-16.99%64 649
EDWARDS LIFESCIENCES CORPORATION-27.19%58 644